Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2023.1138765
Abstract: Background By depleting circulating B lymphocytes, rituximab time-dependently suppresses coronavirus disease 2019 (COVID-19) vaccines’ humoral immunogenicity for a prolonged period. The optimal time to vaccinate rituximab-exposed immune-mediated dermatologic disease (IMDD) patients is currently unclear. Objective… read more here.
Keywords: vaccination; rituximab exposed; optimal time; sars cov ... See more keywords